Jae Hyun Chang Selected Research

AST 120

7/2019	Circulating renalase predicts all-cause mortality and renal outcomes in patients with advanced chronic kidney disease.
1/2018	Erratum: Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea [Volume 36, Issue 1, March 2017, Pages 68-78].
3/2017	Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea.
1/2017	Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease.
4/2016	A Randomized, Controlled Trial of Oral Intestinal Sorbent AST-120 on Renal Function Deterioration in Patients with Advanced Renal Dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jae Hyun Chang Research Topics

Disease

11	Chronic Renal Insufficiency 02/2022 - 11/2009
7	Cardiovascular Diseases (Cardiovascular Disease) 03/2021 - 01/2013
6	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 06/2008
5	Renal Insufficiency (Renal Failure) 03/2021 - 05/2009
5	Vascular Calcification 05/2020 - 02/2012
5	Proteinuria 01/2020 - 08/2010
5	Disease Progression 07/2019 - 04/2016
4	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 10/2012
4	Inflammation (Inflammations) 01/2017 - 04/2012
3	Anemia 02/2022 - 08/2010
3	Hypertension (High Blood Pressure) 01/2021 - 05/2010
2	Infections 02/2022 - 01/2018
2	Body Weight (Weight, Body) 12/2021 - 01/2021
2	Heart Failure 03/2021 - 01/2021
2	Hemorrhage 01/2021 - 01/2014
2	Diabetes Mellitus 01/2021 - 07/2019
2	Hypoalbuminemia 01/2021 - 08/2010
2	Kidney Diseases (Kidney Disease) 11/2019 - 12/2014
2	Critical Illness (Critically Ill) 01/2019 - 01/2014
2	Water Intoxication 03/2018 - 01/2014
2	Acidosis 10/2017 - 06/2009
2	Secondary Hyperparathyroidism 03/2014 - 01/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2010 - 10/2009
2	Hypokalemia 12/2009 - 12/2007
1	Hypernatremia 12/2021
1	Fibrosis (Cirrhosis) 03/2021
1	Muscular Diseases (Myopathy) 01/2021
1	Pruritus (Itching) 11/2019
1	Arteriovenous Fistula 05/2019
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2019
1	Sepsis (Septicemia) 01/2019
1	Hepatitis B 11/2016
1	Immunoglobulin G4-Related Disease 04/2015
1	Anuria 01/2014
1	Weight Gain 01/2014
1	Atherosclerosis 12/2013

Drug/Important Bio-Agent (IBA)

8	CreatinineIBA 01/2021 - 12/2007
5	AST 120IBA 07/2019 - 04/2016
5	C-Reactive ProteinIBA 01/2017 - 12/2007
4	Phosphorus (Red Phosphorus)IBA 11/2019 - 05/2010
3	Biomarkers (Surrogate Marker)IBA 03/2021 - 01/2017
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2014
3	CalciumIBA 11/2019 - 05/2010
3	PotassiumIBA 11/2019 - 12/2009
3	Hemoglobins (Hemoglobin)IBA 07/2019 - 05/2010
3	S100A12 ProteinIBA 01/2017 - 12/2013
3	Receptor for Advanced Glycation End ProductsIBA 01/2017 - 12/2013
3	AlbuminsIBA 01/2017 - 02/2010
3	Serum AlbuminIBA 01/2014 - 12/2007
2	Erythropoietin FDA Link 11/2021 - 01/2011
2	Galectin 3 (LGALS3)IBA 03/2021 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2007
2	Parathyroid Hormone (Parathormone)IBA 11/2019 - 05/2010
2	Carrier Proteins (Binding Protein)IBA 01/2017 - 01/2016
2	NitrogenIBA 01/2014 - 12/2007
2	Uric Acid (Urate)IBA 01/2013 - 11/2009
2	Vitamin D FDA LinkGeneric 01/2013 - 02/2012
2	ResistinIBA 04/2012 - 01/2011
2	CholesterolIBA 02/2010 - 10/2009
2	Triglycerides (Triacylglycerol)IBA 10/2009 - 12/2007
1	omega-Chloroacetophenone (Mace)IBA 02/2022
1	IronIBA 02/2022
1	Epoetin Alfa (Epogen)FDA Link 01/2022
1	Contrast MediaIBA 01/2022
1	Arginine Vasopressin (Argipressin)IBA 12/2021
1	Drinking WaterIBA 12/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	DiureticsIBA 01/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2021
1	WD repeat containing planar cell polarity effectorIBA 05/2020
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2020
1	Phosphates (Orthophosphate)IBA 01/2020
1	AntipruriticsIBA 11/2019
1	Eosinophil Cationic ProteinIBA 11/2019
1	Immunoglobulin E (IgE)IBA 11/2019
1	renalaseIBA 07/2019
1	ORALIT (ORS)IBA 01/2019
1	ProcalcitoninIBA 01/2019
1	hydroxide ionIBA 03/2018
1	SaltsIBA 10/2017
1	SolutionsIBA 10/2017
1	Saline SolutionIBA 10/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2016
1	Hepatitis B AntigensIBA 11/2016
1	Antiviral Agents (Antivirals)IBA 11/2016
1	DNA (Deoxyribonucleic Acid)IBA 11/2016
1	Biological ProductsIBA 01/2016
1	Immunoglobulin G (IgG)IBA 04/2015
1	SteroidsIBA 04/2015
1	Glycogen Synthase (Synthase I)IBA 12/2014
1	MineralsIBA 03/2014
1	Urea (Carbamide)FDA LinkGeneric 01/2014
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2014

Therapy/Procedure

10	Renal Dialysis (Hemodialysis) 02/2022 - 07/2010
7	Therapeutics 02/2022 - 09/2009
5	Peritoneal Dialysis 01/2018 - 10/2009
3	Continuous Ambulatory Peritoneal Dialysis (CAPD) 02/2010 - 12/2007
1	Continuous Renal Replacement Therapy 01/2014